Necrotizing enterocolitis of the newborn: pathogenetic concepts in perspective.
Hsueh
W
W
Department of Pathology, Children's Memorial Hospital, Northwestern University Medical School, Chicago, IL 60614, USA.
Caplan
M S
MS
Tan
X
X
MacKendrick
W
W
Gonzalez-Crussi
F
F
D000818:Animals; D000831:Animals, Newborn; D001381:Azepines / Q000494:pharmacology; D004195:Disease Models, Animal; D004357:Drug Synergism; D020345:Enterocolitis, Necrotizing / Q000139:chemically induced / Q000209:etiology* / Q000473:pathology; D005526:Food, Formulated / Q000009:adverse effects; D006801:Humans; D000860:Hypoxia; D007231:Infant, Newborn; D007422:Intestines / Q000187:drug effects / Q000382:microbiology / Q000473:pathology; D008070:Lipopolysaccharides / Q000009:adverse effects; D051379:Mice; D016328:NF-kappa B / Q000378:metabolism; D009336:Necrosis; D010972:Platelet Activating Factor / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000502:physiology; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D010980:Platelet Membrane Glycoproteins / Q000037:antagonists & inhibitors; D051381:Rats; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D014230:Triazoles / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology
D001381:Azepines; D008070:Lipopolysaccharides; D016328:NF-kappa B; D010972:Platelet Activating Factor; D010975:Platelet Aggregation Inhibitors; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D014230:Triazoles; D014409:Tumor Necrosis Factor-alpha; C039351:platelet activating factor receptor; C052518:WEB 2086; C063964:bepafant